Home
Mergenet Medical, Inc. is an innovative, technology-driven
company that develops and commercializes cutting edge medical devices for therapeutic and diagnostic
applications. Established in
2004, the company’s current product development pipeline includes:
- HiFLO2®, a family product line of non-invasive ventilatory support
systems that deliver warm humidified respiratory gases and are capable of
delivering 100% oxygen to a patient without requiring a face mask. The HiFLO2®
products deliver conditioned gases through a comfortable nasal cannula at
flow rates from 1 l/min for pre-mature infants up to 40 l/min for adults,
such as for high flow therapy (HFT). The HiFLO2® Responz™
establishes a new paradigm in non-invasive ventilation through its state of
the art pressure feedback control of gas flow, and control of temperature,
humidity, and oxygen.
- Trach-Assist®, a family product line of innovative disposable
devices designed to help the clinician manage secretions produced by intubated patients. These products are the first of its kind that allow the
clinician the ability collect and remove respiratory secretions without
having to open or “break” the ventilator circuit. Circuit “breaks” have been
identified as major risk factors of Ventilator Associated Pneumonia (VAP),
as well as lung de-recruitment and hypoxemia.
- CPeX™, a cardiopulmonary diagnostics platform for use by primary
care physicians. This interpretive diagnostic device allows for diagnosis
and differentiation of cardiac and pulmonary diseases. CPeX™
represents our entry into diagnostic devices, which are designed to enhance
the armamentarium of clinicians in caring for their patients, to save
limited health care dollars, and to provide revenue for the physician.
